Glycostem is an innovator in allogeneic cellular immunotherapy using Natural Killer (NK) cells - oNKord® - or antigen presenting cells - sDCord® - for treatment of leukemia, lymphoma and solid tumors.
Find out more
Check out the team that is operating at the cutting edge of immunotherapy
The ability to make cancer a chronic disease
oNKord® is our lead candidate but we are working on more products
Our mould-breaking and loyal supporters
We share all our articles to promote international cooperation